Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mangoceuticals' nicotine pouches are tobacco-free oral delivery systems designed as alternatives to traditional combustible tobacco and vaping products. Developed following the acquisition of intellectual property, product formulations, and related assets from Smokeless Technology Corp. in April 2025, these pouches utilize a pharmaceutical-grade, nutraceutical-based oral-absorption formula to deliver nicotine through the oral mucosa when placed under the lip. The product line is part of Mangoceuticals' strategic expansion into the wellness and preventive health market, leveraging their MangoRx and PeachesRx telemedicine platforms for distribution. The pouches are intended to target the rapidly growing oral nicotine market by providing a smokeless, tobacco-free delivery system for nicotine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Mangoceuticals nicotine pouches.